Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion

Article metrics

Abstract

In the bone marrow, hematopoietic stem cells (HSCs) lodge in specialized microenvironments that tightly control the proliferative state of HSCs to adapt to the varying needs for replenishment of blood cells while also preventing HSC exhaustion1. All putative niche cells suggested thus far have a nonhematopoietic origin2,3,4,5,6,7,8. Thus, it remains unclear how feedback from mature cells is conveyed to HSCs to adjust their proliferation. Here we show that megakaryocytes (MKs) can directly regulate HSC pool size in mice. Three-dimensional whole-mount imaging revealed that endogenous HSCs are frequently located adjacent to MKs in a nonrandom fashion. Selective in vivo depletion of MKs resulted in specific loss of HSC quiescence and led to a marked expansion of functional HSCs. Gene expression analyses revealed that MKs are the source of chemokine C-X-C motif ligand 4 (CXCL4, also named platelet factor 4 or PF4) in the bone marrow, and we found that CXCL4 regulates HSC cell cycle activity. CXCL4 injection into mice resulted in a reduced number of HSCs because of their increased quiescence. By contrast, Cxcl4−/− mice exhibited an increased number of HSCs and increased HSC proliferation. Combined use of whole-mount imaging and computational modeling was highly suggestive of a megakaryocytic niche capable of independently influencing HSC maintenance by regulating quiescence. These results indicate that a terminally differentiated cell type derived from HSCs contributes to the HSC niche, directly regulating HSC behavior.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: The spatial relationship of HSCs and MKs in the bone marrow.
Figure 2: MKs maintain the quiescence of HSCs in vivo.
Figure 3: MKs control HSC quiescence through CXCL4.
Figure 4: MKs regulate HSC quiescence independently of the arteriolar niche.

References

  1. 1

    Orford, K.W. & Scadden, D.T. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat. Rev. Genet. 9, 115–128 (2008).

  2. 2

    Bianco, P. Bone and the hematopoietic niche: a tale of two stem cells. Blood 117, 5281–5288 (2011).

  3. 3

    Mercier, F.E., Ragu, C. & Scadden, D.T. The bone marrow at the crossroads of blood and immunity. Nat. Rev. Immunol. 12, 49–60 (2012).

  4. 4

    Yamazaki, S. et al. Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche. Cell 147, 1146–1158 (2011).

  5. 5

    Ding, L., Saunders, T.L., Enikolopov, G. & Morrison, S.J. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481, 457–462 (2012).

  6. 6

    Frenette, P.S., Pinho, S., Lucas, D. & Scheiermann, C. Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu. Rev. Immunol. 31, 285–316 (2013).

  7. 7

    Kunisaki, Y. et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 502, 637–643 (2013).

  8. 8

    Omatsu, Y. et al. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 33, 387–399 (2010).

  9. 9

    Sato, T. et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469, 415–418 (2011).

  10. 10

    Voog, J., D'Alterio, C. & Jones, D.L. Multipotent somatic stem cells contribute to the stem cell niche in the Drosophila testis. Nature 454, 1132–1136 (2008).

  11. 11

    Mondal, B.C. et al. Interaction between differentiating cell- and niche-derived signals in hematopoietic progenitor maintenance. Cell 147, 1589–1600 (2011).

  12. 12

    Dominici, M. et al. Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation. Blood 114, 2333–2343 (2009).

  13. 13

    Olson, T.S. et al. Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning. Blood 121, 5238–5249 (2013).

  14. 14

    Heazlewood, S.Y. et al. Megakaryocytes co-localise with hemopoietic stem cells and release cytokines that up-regulate stem cell proliferation. Stem Cell Res. 11, 782–792 (2013).

  15. 15

    Tiedt, R., Schomber, T., Hao-Shen, H. & Skoda, R.C. Pf4-cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo. Blood 109, 1503–1506 (2007).

  16. 16

    Minella, A.C. et al. Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo. Genes Dev. 22, 1677–1689 (2008).

  17. 17

    Passegué, E., Wagers, A.J., Giuriato, S., Anderson, W.C. & Weissman, I.L. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J. Exp. Med. 202, 1599–1611 (2005).

  18. 18

    Ito, K. et al. PML targeting eradicates quiescent leukaemia-initiating cells. Nature 453, 1072–1078 (2008).

  19. 19

    Essers, M.A. et al. IFNα activates dormant haematopoietic stem cells in vivo. Nature 458, 904–908 (2009).

  20. 20

    Sato, T. et al. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon–dependent exhaustion. Nat. Med. 15, 696–700 (2009).

  21. 21

    de Graaf, C.A. et al. Regulation of hematopoietic stem cells by their mature progeny. Proc. Natl. Acad. Sci. USA 107, 21689–21694 (2010).

  22. 22

    Stenberg, P.E., Levin, J., Baker, G., Mok, Y. & Corash, L. Neuraminidase-induced thrombocytopenia in mice: effects on thrombopoiesis. J. Cell. Physiol. 147, 7–16 (1991).

  23. 23

    Pinho, S. et al. PDGFRα and CD51 mark human nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion. J. Exp. Med. 210, 1351–1367 (2013).

  24. 24

    Broxmeyer, H.E. et al. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression. J. Immunol. 150, 3448–3458 (1993).

  25. 25

    Lu, L. et al. Comparative effects of suppressive cytokines on isolated single CD343+ stem/progenitor cells from human bone marrow and umbilical cord blood plated with and without serum. Exp. Hematol. 21, 1442–1446 (1993).

  26. 26

    Han, Z.C., Sensebe, L., Abgrall, J.F. & Briere, J. Platelet factor 4 inhibits human megakaryocytopoiesis in vitro. Blood 75, 1234–1239 (1990).

  27. 27

    Broxmeyer, H.E. et al. Synergistic inhibition in vivo of bone marrow myeloid progenitors by myelosuppressive chemokines and chemokine-accelerated recovery of progenitors after treatment of mice with Ara-C. Exp. Hematol. 34, 1069–1077 (2006).

  28. 28

    Han, Z.C. et al. Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents. Blood 89, 2328–2335 (1997).

  29. 29

    Maione, T.E. et al. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247, 77–79 (1990).

  30. 30

    Eslin, D.E. et al. Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin. Blood 104, 3173–3180 (2004).

  31. 31

    Zhao, M. et al. Megakaryocytes maintain homeostatic quiescence and promote regeneration of hematopoietic stem cells after injury. Nat. Med. 10.1038/nm.3706 (19 October 2014).

  32. 32

    Fasano, G. & Franceschini, A. A multidimensional version of the Kolmogorov-Smirnov test. Mon. Not. R. Astron. Soc. 225, 155–170 (1987).

  33. 33

    Press, W.H. & Numerical Recipes Software (Firm) Numerical recipes in C. (Cambridge University Press, Cambridge, England, New York, N.Y., 1992).

  34. 34

    Peacock, J.A. Two-dimensional goodness-of-fit testing in astronomy. Mon. Not. R. Astron. Soc. 202, 615–627 (1983).

  35. 35

    Hsu, Y.C., Pasolli, H.A. & Fuchs, E. Dynamics between stem cells, niche, and progeny in the hair follicle. Cell 144, 92–105 (2011).

  36. 36

    Chow, A. et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J. Exp. Med. 208, 261–271 (2011).

  37. 37

    Winkler, I.G. et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 116, 4815–4828 (2010).

  38. 38

    Christopher, M.J., Rao, M., Liu, F., Woloszynek, J.R. & Link, D.C. Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J. Exp. Med. 208, 251–260 (2011).

  39. 39

    Sanjuan-Pla, A. et al. Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy. Nature 502, 232–236 (2013).

  40. 40

    Aivado, M. et al. Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease. Proc. Natl. Acad. Sci. USA 104, 1307–1312 (2007).

  41. 41

    Mignone, J.L., Kukekov, V., Chiang, A.S., Steindler, D. & Enikolopov, G. Neural stem and progenitor cells in nestin-GFP transgenic mice. J. Comp. Neurol. 469, 311–324 (2004).

  42. 42

    Shivdasani, R.A. & Schulze, H. Culture, expansion, and differentiation of murine megakaryocytes. Curr. Protoc. Immunol. 67, 22F.6 (2005).

  43. 43

    Hu, Y. & Smyth, G.K. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods 347, 70–78 (2009).

Download references

Acknowledgements

We thank C. Prophete and P. Ciero for mouse husbandry and L. Tesfa, O. Uche and J. Zhang for technical assistance with sorting. I.B. was supported by the American Society of Hematology–European Hematology Association (ASH-EHA) research exchange award and the University of Düsseldorf. S.P. is a New York Stem Cell Foundation–Druckenmiller Fellow. J.A. was supported by the Integrated Training in Pharmacological Science program, NIGMS T32 063754. This work was supported by the New York Stem Cell Foundation and the New York State Department of Health (NYSTEM Program) and by grants from the US National Institutes of Health (NIH; R01 grants DK056638 and HL069438 to P.S.F., CA164468 and DA033788 to A.B. and P01 HL110860 and U01 HL099656 to M.P.).

Author information

I.B., D.L. and S.P. designed the study, performed the majority of the experiments and analyzed data. J.A. and A.B. performed computational modeling and statistical analysis of the data. M.P.L. performed imaging of CXCL4 in MKs and provided mice. C.S. and Y.K. contributed to the processing and imaging of whole-mount bone marrow tissues. L.S. genotyped mice. M.P. provided mice and interpreted data. P.S.F. and A.B. supervised the study. I.B., D.L., S.P., A.B. and P.S.F. wrote the manuscript. All authors discussed the results and commented on the manuscript.

Correspondence to Aviv Bergman or Paul S Frenette.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–10 and Supplementary Tables 1–5 (PDF 12407 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bruns, I., Lucas, D., Pinho, S. et al. Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion. Nat Med 20, 1315–1320 (2014) doi:10.1038/nm.3707

Download citation

Further reading